* Predictive Oncology Inc POAI.OQ POAI.O is expected
to show a
rise in quarterly revenue when it reports results on March 21.
* The Eagan Minnesota-based company is expected to report
a
5.0% increase in revenue to $500 thousand from $476 thousand a
year ago, according to the estimate from one analyst, based on
Refinitiv data.
* Refinitiv's mean analyst estimate for Predictive Oncology
Inc
is for a loss of 6 cents per share.
* The one available analyst rating on the shares is "buy".
* The average consensus recommendation for the medical
equipment,
supplies & distribution peer group is also "Buy".
* Wall Street's median 12-month price target for Predictive
Oncology Inc is $5, above its last closing price of $0.34.
This summary was machine generated March 17 at 20:02 GMT. All
figures in US dollars unless otherwise stated